CS logo
small CS logo
ForCare Clinical Research

Tampa, Florida, United States
Medical clinic in the Lake Magdalene, Florida
15416 N Florida Ave, Tampa, FL 33613

About ForCare Clinical Research


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
29
Pfizer
18
Incyte Corporation
3
Concert Pharmaceuticals
2
RAPT Therapeutics, Inc.
2
ASLAN Pharmaceuticals
1
Aristea Therapeutics, Inc.
1
Bristol-Myers Squibb
1
Celgene
1
Celldex Therapeutics
1
Evelo Biosciences, Inc.
1
Total Rows: 14

Clinical Trials at ForCare Clinical Research


During the past decade, ForCare Clinical Research conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 25 clinical trials were completed, i.e. on average, 39.7% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 25 clinical trials were completed. i.e. 80.6% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years110015151616141466101011000000002255111177Started TrialsCompleted Trails2016201720182019202020212022202301020
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis
2016-04-27
2021-03-09
Completed
97
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
2018-03-14
2026-11-30
Recruiting
325
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
2018-02-20
2021-08-16
Completed
440
A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD
2018-04-27
2020-12-11
Terminated
237
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
2018-09-03
2022-02-07
Terminated
1,936
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
2018-06-27
2022-06-13
Terminated
374
A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
2018-10-30
2024-06-24
Active, not recruiting
824
A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis
2018-11-09
2020-01-08
Completed
1,027

Rows per page:

1–63 of 63

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "ForCare Clinical Research" #1 sponsor was "Eli Lilly and Company" with 29 trials, followed by "Pfizer" with 18 trials sponsored, "Incyte Corporation" with 3 trials sponsored, "Concert Pharmaceuticals" with 2 trials sponsored and "RAPT Therapeutics, Inc." with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "ForCare Clinical Research" #1 collaborator was "Incyte Corporation" with 7 trials as a collaborator, "Dermira, Inc." with 5 trials as a collaborator, "Nektar Therapeutics" with 2 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 29Eli Lilly and Company: 29Pfizer: 18Pfizer: 18Incyte Corporation: 3Incyte Corporation: 3Concert Pharmaceuticals: 2Concert Pharmaceuticals: 2RAPT Therapeutics, Inc.: 2RAPT Therapeutics, Inc.: 2ASLAN Pharmaceuticals: 1ASLAN Pharmaceuticals: 1Aristea Therapeutics, Inc.: 1Aristea Therapeutics, Inc.: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Celgene: 1Celgene: 1Celldex Therapeutics: 1Celldex Therapeutics: 1

Created with Highcharts 11.1.0Top CollaboratorsIncyte Corporation: 7Incyte Corporation: 7Dermira, Inc.: 5Dermira, Inc.: 5Nektar Therapeutics: 2Nektar Therapeutics: 2Galapagos NV: 1Galapagos NV: 1

Clinical Trials Conditions at ForCare Clinical Research


According to Clinical.Site data, the most researched conditions in "ForCare Clinical Research" are "Atopic Dermatitis" (17 trials), "Alopecia Areata" (6 trials), "Psoriasis" (6 trials), "Dermatitis, Atopic" (5 trials) and "Migraine" (4 trials). Many other conditions were trialed in "ForCare Clinical Research" in a lesser frequency.

Clinical Trials Intervention Types at ForCare Clinical Research


Most popular intervention types in "ForCare Clinical Research" are "Drug" (57 trials), "Biological" (8 trials), "Other" (7 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (38 trials), "Baricitinib" (7 trials), "Lebrikizumab" (6 trials), "PF-04965842 100 mg" (3 trials) and "PF-04965842 200 mg" (3 trials). Other intervention names were less common.

Clinical Trials Genders at ForCare Clinical Research


The vast majority of trials in "ForCare Clinical Research" are 63 trials for "All" genders.

Clinical Trials Status at ForCare Clinical Research


Currently, there are NaN active trials in "ForCare Clinical Research". undefined are not yet recruiting, 14 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 28 completed trials in ForCare Clinical Research, undefined suspended trials, and 9 terminated clinical trials to date.
Out of the total trials that were conducted in ForCare Clinical Research, 7 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 35Phase 3: 35Phase 2: 21Phase 2: 21Phase 1: 7Phase 1: 7Phase 4: 4Phase 4: 4

Created with Highcharts 11.1.0Trials StatusCompleted: 28Completed: 28Recruiting: 14Recruiting: 14Active, not recruiting: 10Active, not recruiting: 10Terminated: 9Terminated: 9Enrolling by invitation: 1Enrolling by invitation: 1Withdrawn: 1Withdrawn: 1